Literature DB >> 29526282

A History of Percutaneous Left Atrial Appendage Occlusion with the PLAATO Device.

Heyder Omran1, Apostolos Tzikas2, Horst Sievert3, Frederike Stock4.   

Abstract

Percutaneous left atrial appendage occlusion was introduced as an alternative method for prevention of thromboembolism in patients with nonvalvular atrial fibrillation after extensive animal work in 2001. The first device was named Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO) and patented by the company Appriva. The device was invented by Michael Lesh, MD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Left atrial appendage; Left atrial appendage occlusion; PLAATO

Mesh：

Year:  2018        PMID： 29526282     DOI： 10.1016/j.iccl.2017.12.009

Source DB:  PubMed          Journal:  Interv Cardiol Clin        ISSN： 2211-7458


  1 in total

1.  Percutaneous Occlusion of Left Atrial Appendage: Growing Clinical Experience and Lack of Multicenter Randomized Clinical Trials.

Authors:  Cristiano F Pisani; Mauricio Scanavacca
Journal:  Arq Bras Cardiol       Date:  2019-11-04       Impact factor: 2.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.